DENTSPLY SIRONA Inc. (XRAY)
USD 18.68
(-2.66%)
USD 18.68
(-2.66%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 232 Million USD | 137.61% |
| 2022 | -677 Million USD | -36.73% |
| 2021 | 972 Million USD | 26.84% |
| 2020 | 336 Million USD | -6.52% |
| 2019 | 706.6 Million USD | -57.45% |
| 2018 | -585.3 Million USD | -23.98% |
| 2017 | -1.25 Billion USD | 238.11% |
| 2016 | 770.5 Million USD | 53.15% |
| 2015 | 579.3 Million USD | 7.87% |
| 2014 | 575.24 Million USD | 4.91% |
| 2013 | 544.88 Million USD | 2.89% |
| 2012 | 513.33 Million USD | 28.75% |
| 2011 | 378.7 Million USD | -16.32% |
| 2010 | 439.99 Million USD | 3.65% |
| 2009 | 437.27 Million USD | -20.28% |
| 2008 | 444.32 Million USD | 15.79% |
| 2007 | 432.26 Million USD | 9.83% |
| 2006 | 373.21 Million USD | -34.24% |
| 2005 | 138.99 Million USD | 61.69% |
| 2004 | 348.77 Million USD | 14.79% |
| 2003 | 317.34 Million USD | 3.5% |
| 2002 | 297.62 Million USD | 44.0% |
| 2001 | 232.69 Million USD | 1.17% |
| 2000 | 205.21 Million USD | 11.7% |
| 1999 | 189.2 Million USD | -25.43% |
| 1998 | 178.7 Million USD | 53.57% |
| 1997 | 164.9 Million USD | 12.14% |
| 1996 | 147.6 Million USD | 17.12% |
| 1995 | 122.2 Million USD | 7.47% |
| 1994 | 117.5 Million USD | 14.29% |
| 1993 | 98.6 Million USD | 533.96% |
| 1992 | 31.6 Million USD | 55.88% |
| 1991 | 15.6 Million USD | 51.46% |
| 1990 | 10.3 Million USD | 74.58% |
| 1989 | 5.9 Million USD | 84.38% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 137 Million USD | 15.44% |
| 2024 Q1 | 138 Million USD | -12.82% |
| 2023 Q4 | 161 Million USD | 211.81% |
| 2023 Q1 | 76 Million USD | -28.3% |
| 2023 FY | - USD | 0.63% |
| 2023 Q3 | -144 Million USD | -194.12% |
| 2023 Q2 | 153 Million USD | 101.32% |
| 2022 Q4 | 34 Million USD | -76.06% |
| 2022 Q3 | 142 Million USD | -27.92% |
| 2022 Q2 | 197 Million USD | 8.24% |
| 2022 Q1 | 182 Million USD | 9.64% |
| 2022 FY | - USD | -36.73% |
| 2021 Q2 | 243 Million USD | -4.33% |
| 2021 FY | - USD | 26.84% |
| 2021 Q4 | 166 Million USD | -30.54% |
| 2021 Q1 | 254 Million USD | 53.94% |
| 2021 Q3 | 239 Million USD | -1.65% |
| 2020 Q3 | 188 Million USD | 786.13% |
| 2020 FY | - USD | -6.52% |
| 2020 Q1 | 352.8 Million USD | 118.05% |
| 2020 Q4 | 165 Million USD | -12.23% |
| 2020 Q2 | -27.4 Million USD | -107.77% |
| 2019 FY | - USD | -57.45% |
| 2019 Q2 | 180.8 Million USD | 9.05% |
| 2019 Q4 | 161.8 Million USD | -17.83% |
| 2019 Q3 | 196.9 Million USD | 8.9% |
| 2019 Q1 | 165.8 Million USD | 63.51% |
| 2018 Q1 | 89.1 Million USD | -91.69% |
| 2018 Q4 | 101.4 Million USD | -26.36% |
| 2018 Q3 | 137.7 Million USD | -90.13% |
| 2018 FY | - USD | -23.98% |
| 2018 Q2 | 1.39 Billion USD | 1465.99% |
| 2017 Q4 | 1.07 Billion USD | 619.11% |
| 2017 FY | - USD | 238.11% |
| 2017 Q3 | 149.1 Million USD | -24.39% |
| 2017 Q2 | 197.2 Million USD | 18.44% |
| 2017 Q1 | 166.5 Million USD | 11.45% |
| 2016 FY | - USD | 53.15% |
| 2016 Q1 | 126.2 Million USD | 4.56% |
| 2016 Q4 | 149.4 Million USD | -28.72% |
| 2016 Q3 | 209.6 Million USD | 2.85% |
| 2016 Q2 | 203.8 Million USD | 61.49% |
| 2015 FY | - USD | 7.87% |
| 2015 Q3 | 111.8 Million USD | -31.65% |
| 2015 Q4 | 120.7 Million USD | 7.96% |
| 2015 Q2 | 163.56 Million USD | 50.66% |
| 2015 Q1 | 108.56 Million USD | -6.76% |
| 2014 Q3 | 145.34 Million USD | -10.5% |
| 2014 Q1 | 141.34 Million USD | 23.99% |
| 2014 FY | - USD | 4.91% |
| 2014 Q4 | 116.43 Million USD | -19.89% |
| 2014 Q2 | 162.39 Million USD | 14.89% |
| 2013 Q1 | 126.13 Million USD | 13.72% |
| 2013 Q2 | 155.88 Million USD | 23.59% |
| 2013 Q3 | 138.87 Million USD | -10.91% |
| 2013 Q4 | 114 Million USD | -17.91% |
| 2013 FY | - USD | 2.89% |
| 2012 Q1 | 88.39 Million USD | -3.16% |
| 2012 Q2 | 146.24 Million USD | 65.44% |
| 2012 Q3 | 134.53 Million USD | -8.01% |
| 2012 Q4 | 110.91 Million USD | -17.55% |
| 2012 FY | - USD | 28.75% |
| 2011 Q1 | 118.62 Million USD | -0.21% |
| 2011 FY | - USD | -16.32% |
| 2011 Q4 | 91.28 Million USD | 37.98% |
| 2011 Q3 | 66.15 Million USD | -47.42% |
| 2011 Q2 | 125.81 Million USD | 6.06% |
| 2010 Q2 | 122.45 Million USD | 8.78% |
| 2010 Q3 | 107.93 Million USD | -11.86% |
| 2010 Q4 | 118.87 Million USD | 10.14% |
| 2010 FY | - USD | 3.65% |
| 2010 Q1 | 112.58 Million USD | -6.88% |
| 2009 Q4 | 120.89 Million USD | 28.42% |
| 2009 FY | - USD | -20.28% |
| 2009 Q3 | 94.14 Million USD | -7.55% |
| 2009 Q1 | 106.06 Million USD | 2.25% |
| 2009 Q2 | 101.83 Million USD | -3.99% |
| 2008 Q4 | 103.73 Million USD | -22.67% |
| 2008 Q2 | 130.17 Million USD | 9.62% |
| 2008 Q1 | 118.75 Million USD | 10.11% |
| 2008 FY | - USD | 15.79% |
| 2008 Q3 | 134.13 Million USD | 3.04% |
| 2007 Q4 | 107.85 Million USD | 3.05% |
| 2007 Q1 | 95.91 Million USD | -2.67% |
| 2007 FY | - USD | 9.83% |
| 2007 Q2 | 111.97 Million USD | 16.75% |
| 2007 Q3 | 104.66 Million USD | -6.53% |
| 2006 FY | - USD | -34.24% |
| 2006 Q4 | 98.55 Million USD | 10.6% |
| 2006 Q3 | 89.1 Million USD | -14.43% |
| 2006 Q2 | 104.13 Million USD | 14.45% |
| 2006 Q1 | 90.98 Million USD | -52.27% |
| 2005 Q2 | 92.68 Million USD | 16.07% |
| 2005 Q3 | 218.93 Million USD | 136.22% |
| 2005 Q4 | 190.63 Million USD | -12.93% |
| 2005 Q1 | 79.85 Million USD | -20.29% |
| 2005 FY | - USD | 61.69% |
| 2004 Q1 | 84.8 Million USD | 4.79% |
| 2004 Q4 | 100.18 Million USD | 18.29% |
| 2004 Q3 | 84.69 Million USD | -6.26% |
| 2004 Q2 | 90.34 Million USD | 6.54% |
| 2004 FY | - USD | 14.79% |
| 2003 Q1 | 74.1 Million USD | -15.87% |
| 2003 Q4 | 82.02 Million USD | 6.8% |
| 2003 Q3 | 77.29 Million USD | -9.11% |
| 2003 Q2 | 83.91 Million USD | 13.31% |
| 2003 FY | - USD | 3.5% |
| 2002 FY | - USD | 44.0% |
| 2002 Q3 | 70.74 Million USD | -8.14% |
| 2002 Q4 | 83.37 Million USD | 20.45% |
| 2002 Q1 | 65.32 Million USD | 11.9% |
| 2002 Q2 | 77.5 Million USD | 23.61% |
| 2001 Q3 | 58.63 Million USD | -11.12% |
| 2001 Q4 | 62.88 Million USD | -5.28% |
| 2001 Q1 | 53.11 Million USD | -40.47% |
| 2001 Q2 | 58.06 Million USD | 89.67% |
| 2001 FY | - USD | 1.17% |
| 2000 Q4 | 58.45 Million USD | 21.25% |
| 2000 Q3 | 48.65 Million USD | -2.42% |
| 2000 Q2 | 50.63 Million USD | 6.96% |
| 2000 Q1 | 47.47 Million USD | -11.88% |
| 2000 FY | - USD | 11.7% |
| 1999 Q3 | 44.55 Million USD | 1.38% |
| 1999 FY | - USD | -25.43% |
| 1999 Q1 | 44.9 Million USD | -53.42% |
| 1999 Q2 | 44.22 Million USD | -1.58% |
| 1999 Q4 | 55.5 Million USD | 22.22% |
| 1998 Q3 | 41.4 Million USD | -43.38% |
| 1998 Q4 | 52.2 Million USD | 126.49% |
| 1998 FY | - USD | 53.57% |
| 1998 Q1 | 40.6 Million USD | -23.43% |
| 1998 Q2 | 44.5 Million USD | 90.23% |
| 1997 Q2 | 40.6 Million USD | 20.3% |
| 1997 FY | - USD | 12.14% |
| 1997 Q4 | 50.4 Million USD | 33.33% |
| 1997 Q3 | 38 Million USD | -5.46% |
| 1997 Q1 | 36 Million USD | -23.52% |
| 1996 Q2 | 38.4 Million USD | 15.34% |
| 1996 FY | - USD | 17.12% |
| 1996 Q4 | 43.7 Million USD | 42.21% |
| 1996 Q3 | 31.4 Million USD | -18.09% |
| 1996 Q1 | 33.9 Million USD | -16.2% |
| 1995 FY | - USD | 7.47% |
| 1995 Q4 | 38.6 Million USD | 71.37% |
| 1995 Q3 | 23.7 Million USD | -34.58% |
| 1995 Q2 | 32.2 Million USD | 26.18% |
| 1995 Q1 | 27.7 Million USD | -8.33% |
| 1994 FY | - USD | 14.29% |
| 1994 Q1 | 28.4 Million USD | -7.54% |
| 1994 Q2 | 30.5 Million USD | 5.67% |
| 1994 Q3 | 29.6 Million USD | 0.0% |
| 1994 Q4 | 31.5 Million USD | 0.67% |
| 1993 FY | - USD | 533.96% |
| 1993 Q4 | 33.9 Million USD | 8.93% |
| 1993 Q3 | 27.7 Million USD | 85.43% |
| 1993 Q2 | 13.9 Million USD | 54.08% |
| 1993 Q1 | 9.8 Million USD | 8.89% |
| 1992 Q2 | 5.1 Million USD | 23.4% |
| 1992 FY | - USD | 55.88% |
| 1992 Q3 | 7.8 Million USD | 44.83% |
| 1992 Q4 | 9 Million USD | 7.14% |
| 1992 Q1 | 4.7 Million USD | 14.63% |
| 1991 Q2 | 3.2 Million USD | -8.57% |
| 1991 Q3 | 3.8 Million USD | 18.75% |
| 1991 FY | - USD | 72.88% |
| 1991 Q1 | 3.5 Million USD | 0.0% |
| 1991 Q4 | 4.1 Million USD | 7.89% |
| 1990 Q4 | 3.5 Million USD | 75.0% |
| 1990 FY | - USD | 90.32% |
| 1990 Q3 | 2 Million USD | 33.33% |
| 1990 Q2 | 1.5 Million USD | 7.14% |
| 1990 Q1 | 1.4 Million USD | -12.5% |
| 1989 Q4 | 1.6 Million USD | 6.67% |
| 1989 Q1 | -11.3 Million USD | -330.61% |
| 1989 Q3 | 1.5 Million USD | 0.0% |
| 1989 Q2 | 1.5 Million USD | 113.27% |
| 1989 FY | - USD | 6.9% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 608.415% |
| AngioDynamics, Inc. | -14.29 Million USD | 1723.286% |
| AtriCure, Inc. | -8.1 Million USD | 2961.019% |
| Avinger, Inc. | -16.34 Million USD | 1519.307% |
| Azenta, Inc. | 55.15 Million USD | -320.663% |
| BioLife Solutions, Inc. | -45.23 Million USD | 612.843% |
| The Cooper Companies, Inc. | 882.8 Million USD | 73.72% |
| Daxor Corporation | 329.74 Thousand USD | -70258.464% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 1857.842% |
| Femasys Inc. | -13.16 Million USD | 1861.658% |
| GlucoTrack, Inc. | -7.09 Million USD | 3371.753% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -2343.906% |
| Hologic, Inc. | 1.29 Billion USD | 82.102% |
| ICU Medical, Inc. | 307.69 Million USD | 24.6% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 90.31% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 2568.193% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | -373.566% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 3628.445% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 3628.445% |
| Masimo Corporation | 236.7 Million USD | 1.986% |
| Microbot Medical Inc. | -10.63 Million USD | 2281.681% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -1371.096% |
| Merit Medical Systems, Inc. | 231.44 Million USD | -0.241% |
| Nephros, Inc. | -1.37 Million USD | 16923.785% |
| NovoCure Limited | -175.86 Million USD | 231.919% |
| NEXGEL, Inc. | -2.73 Million USD | 8598.168% |
| NEXGEL, Inc. | -2.73 Million USD | 8598.168% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 368.22% |
| OraSure Technologies, Inc. | 76.15 Million USD | -204.63% |
| Pro-Dex, Inc. | 8.33 Million USD | -2684.111% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 647.596% |
| Predictive Oncology Inc. | -13.18 Million USD | 1859.974% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 9335.849% |
| QuidelOrtho Corporation | 545.6 Million USD | 57.478% |
| Repligen Corporation | 124.29 Million USD | -86.657% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 80349.882% |
| STAAR Surgical Company | 33.22 Million USD | -598.353% |
| Sharps Technology, Inc. | -8.98 Million USD | 2683.406% |
| Utah Medical Products, Inc. | 24.8 Million USD | -835.295% |
| Jin Medical International Ltd. | 3.44 Million USD | -6638.535% |